Intrexon's ActoBio Therapeutics to Present at Biotech Showcase 2018 on January 8

Intrexon Corporation logo. (PRNewsFoto/Intrexon Corporation)GHENT, Belgium, Jan. 4, 2018 /PRNewswire/ -- ActoBio Therapeutics, Inc., a wholly owned subsidiary of Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that Pieter...


Insights

Enewsletters

Sponsored Introduction Continue on to (or wait seconds) ×